Picture of BioArctic AB logo

BIOA B BioArctic AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Brief: Bioarctic Receives Positive Opinion For Orphan Medicinal Product Designation In EU

May 22 (Reuters) - BioArctic AB BIOAb.ST:

BIOARCTIC RECEIVES POSITIVE OPINION FOR ORPHAN MEDICINAL PRODUCT DESIGNATION IN THE EU FOR EXIDAVNEMAB IN MULTIPLE SYSTEM ATROPHY

Source text: ID:nWkr7g9xFr

Further company coverage: [BIOAb.ST]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on BioArctic AB

See all news